- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06697249
Feasibility of Valve-in-Root Transcatheter Aortic Valve Implantation in 363 Patients After Aortic Root Replacement and Repair (Valve in Root)
Feasibility of Valve-in-Root Transcatheter Aortic Valve Implantation in 363 Patients After Aortic Root Replacement and Repair: a Retrospective Computed-tomography Analysis
Biological replacement of the aortic valve in the sense of a complete root replacement is the therapy for a dilatation or aneurysm of the ascending aorta, which also involves the aortic valve. In some patients, the aortic valve can be preserved, which means that only reconstruction is necessary instead of a complete replacement of the root. For a root replacement or root reconstruction, both coronary arteries must be prepared at their origin from the aorta and reimplanted into a tubular prosthesis. It is known that biological aortic valve prostheses have a lifespan of between 10-20 years depending on the type and design of the valve and that the first degenerative symptoms become visible after 10-12 years. This is particularly relevant for patients who have their initial operation at a younger age and require a follow-up procedure if the valve degenerates at an older age.
The minimally invasive implantation of transcatheter valves has proven to be a successful method, avoiding a second operation with an increased risk of mortality. The so-called valve-in-valve procedures are carried out particularly in older patients and are now standard in modern valve treatment. The feasibility of a valve-in-valve in the aortic position requires certain anatomical conditions, which can be influenced by the surgeon's implantation technique in the case of additional root replacement. In particular, there is a risk of coronary artery occlusion when implanting the transcatheter valve, which is increased if the coronary artery branches are located below the valve level. In addition, the selection of the prosthesis size is an important parameter for subsequently implanting a suitably large transcatheter valve.
The aim of this study is to use postoperative computer tomography of patients after root replacement/reconstruction to measure the anatomical parameters that describe a possible implantation of a transcatheter valve in the event of degeneration of the initial valve. This simultaneously shows the quality of the root replacement/reconstruction with regard to a plannable follow-up procedure and can also show for the future how the surgical technique could be modified to make a minimally invasive follow-up intervention available to more patients.
This study aims to answer the question of whether the patients who were treated with biological root replacement or reconstruction in the years 2012-2022 for aortic valve failure are anatomically suitable for valve-in-valve therapy based on the postoperative computed tomography measurements of the aortic root. In addition, the measurements provide a surgical answer to the question of whether relevant parameters such as the distance between the coronary arteries were sufficiently taken into account during the initial operation or whether an improvement should be made in the future while adhering to the anatomically important parameters during the initial procedure.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Freiburg, Germany, 79106
- University hospital Freiburg, Department of Cardiovascular Surgery
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- all patients over 18 years after biological aortic root replacement or repair
- postoperative ECG-gated CT-angiography scan
Exclusion Criteria:
- mechanical aortic root replacements (not suitable for Valve-in-Root treatment)
- missing postoperative ECG-gated CT-angiography scan
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
RR patients
Patients after biological aortic root replacement
|
CT scans of patients after biological root replacement and root repair were assessed with the 3mensio Software (Aortic valve package, 3mensio 10.1, Pie Medical Imaging.
Before carrying out the measurements, markers for alignment of the aortic root and ascending aorta were placed manually.
The annular area was measured for both groups.
In patients after biological root replacement the area of the annulus was defined as the ring of the initial aortic valve prosthesis.
Coronary buttons were measured at their lowest and highest point to define partial or full position below the valve level and the general button size.
For assessment of the annular-to-coronary distance, the lower edge of the coronary button was chosen.
VTC was assessed after root replacement in patients who had at least one coronary partially under the level of the valve.
For this measurement a virtually inserted valve was placed in the bioprosthetic frame.
|
|
VSRR patients
Patients after valve-sparing aortic root replacement
|
CT scans of patients after biological root replacement and root repair were assessed with the 3mensio Software (Aortic valve package, 3mensio 10.1, Pie Medical Imaging.
Before carrying out the measurements, markers for alignment of the aortic root and ascending aorta were placed manually.
The annular area was measured for both groups.
In patients after biological root replacement the area of the annulus was defined as the ring of the initial aortic valve prosthesis.
Coronary buttons were measured at their lowest and highest point to define partial or full position below the valve level and the general button size.
For assessment of the annular-to-coronary distance, the lower edge of the coronary button was chosen.
VTC was assessed after root replacement in patients who had at least one coronary partially under the level of the valve.
For this measurement a virtually inserted valve was placed in the bioprosthetic frame.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
CT-measurement: Aortic annulus area
Time Frame: January 2024-June 2024
|
January 2024-June 2024
|
|
CT-measurement: Valve-to-coronary distance
Time Frame: January 2024-June 2024
|
January 2024-June 2024
|
|
CT measurement: Annulus-to-coronary distance
Time Frame: January 2024-June 2024
|
January 2024-June 2024
|
|
CT-measurement: Size of coronary buttons
Time Frame: January 2024-June 2024
|
January 2024-June 2024
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ViR 2024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transcatheter Aortic Valve Replacement
-
Medical University of South CarolinaCompletedTranscatheter Aortic Valve ReplacementUnited States
-
Cara Medical LtdTerminatedTranscatheter Aortic Valve ReplacementUnited States
-
Cara Medical LtdCompletedTranscatheter Aortic Valve ReplacementSpain, Italy, Canada
-
Filterlex Medical Ltd.Completed
-
University of Maryland, BaltimoreRecruiting
-
Centre Hospitalier Universitaire de NīmesMedtronicCompletedTranscatheter Aortic Valve ReplacementFrance
-
Drägerwerk AG & Co. KGaACompletedTranscatheter Aortic Valve ReplacementGermany
-
BayerJanssen Research & Development, LLCTerminatedTranscatheter Aortic Valve ReplacementBelgium, France, Germany, Spain, United States, Switzerland, Canada, Austria, United Kingdom, Korea, Republic of, Denmark, Italy, Netherlands, Poland, Czechia, Sweden, Norway
-
Action, FranceUnknownTranscatheter Aortic Valve ReplacementFrance
-
Technical University of MunichDeutsches Herzzentrum Muenchen; Klinikum der Universitaet Muenchen, GrosshadernCompletedTranscatheter Aortic Valve ReplacementGermany
Clinical Trials on Analysis of postoperative CT scans checking for the feasibility of transcatheter valve-in-root implantation
-
University Hospital, Basel, SwitzerlandRecruitingAortic StenosisAustria, Switzerland, Germany
-
Henry Ford Health SystemCompleted
-
Maria Cecilia HospitalRecruiting
-
Centre Leon BerardUnknown
-
Zhejiang Cancer HospitalFudan University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsCompletedStage III Non-small-Cell Lung CancerChina
-
Jaeb Center for Health ResearchActive, not recruitingCystic FibrosisUnited States